Literature DB >> 10478705

Evidence against permanent neurologic damage from nonconvulsive status epilepticus.

F W Drislane1.   

Abstract

Nonconvulsive status epilepticus (NCSE) is much more common than is generally appreciated and is certainly underdiagnosed, but its long-term effects are largely undetermined and remain controversial. There is increasing experimental evidence that generalized convulsive status epilepticus produces lasting neuropathologic damage in the hippocampus, but experimental models often include provocation of status epilepticus (SE) by physical (e.g., electrical stimulation) and chemical (including excitotoxic) agents that may induce damage independent of the epileptiform discharges. Also, damage appears to be related to the intensity and duration of electrical stimulation. Such models usually include high-frequency discharges sustained over long periods, somewhat different from the electrical activity of typical human NCSE. Pathologic studies in humans pertain primarily to patients who have had generalized convulsive status epilepticus. Clinical studies of the effects of NCSE are mandatory, but conclusions are difficult to come by, in part because of diverse definitions of NCSE. An altered mental status is obligatory, but the pertinent EEG and medication response criteria are controversial. Response to medication can be delayed by many hours or even days. Absence SE appears to cause no lasting effects. Complex partial SE is less uniform. Most reported cases have returned to baseline neurologic function, but several well-described patients have had prolonged memory deficits. The significance of other deficits is difficult to interpret in light of concomitant vascular and other diseases causing neurologic dysfunction. Clinical series usually lack premorbid neurologic and neuropsychologic assessment. The few exceptions are complicated by preexisting mental retardation and other deficits, by the coexistence of progressive illness, by the later effects of recurrent seizures, and almost always by the confounding influence of anticonvulsant medications. Most morbidity appears attributable to the underlying illnesses rather than to the NCSE itself. It is possible that relatively infrequent cases of prolonged NCSE or those with the synergistic effect of concomitant systemic illness, focal lesions, or very rapid excitatory epileptiform discharges may suffer more long-lasting damage, but these observations are still preliminary. NCSE should be treated expeditiously because of the acute neurologic impairment of the patients, because of the attendant morbidity including physical injury, and because it may go on to generalized convulsions. There is reasonable concern about possible long-term effects, but permanent neurologic damage from NCSE has not yet been established as a mandate for urgent treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10478705     DOI: 10.1097/00004691-199907000-00004

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  9 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

Review 2.  Continuous electroencephalogram monitoring in the critically ill.

Authors:  John J Wittman; Lawrence J Hirsch
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Localisation-related nonconvulsive status epilepticus: Further evidence of permanent cerebral damage.

Authors:  José L Fernández-Torre; Javier Figols; Marián Martínez-Martínez; Jesús González-Rato; Jesús Calleja
Journal:  J Neurol       Date:  2005-09-02       Impact factor: 4.849

4.  Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting.

Authors:  Stephan J. Rüegg; Marc A. Dichter
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

5.  Absence of early epileptiform abnormalities predicts lack of seizures on continuous EEG.

Authors:  Mouhsin M Shafi; M Brandon Westover; Andrew J Cole; Ronan D Kilbride; Daniel B Hoch; Sydney S Cash
Journal:  Neurology       Date:  2012-10-10       Impact factor: 9.910

Review 6.  Diagnosis and treatment of nonconvulsive status epilepticus.

Authors:  M C Walker
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation.

Authors:  A O Rossetti; S Hurwitz; G Logroscino; E B Bromfield
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

8.  Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy.

Authors:  Andrea O Rossetti; Giancarlo Logroscino; Tracey A Milligan; Costas Michaelides; Christiane Ruffieux; Edward B Bromfield
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

9.  Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomes.

Authors:  Jan Claassen; Adler Perotte; David Albers; Samantha Kleinberg; J Michael Schmidt; Bin Tu; Neeraj Badjatia; Hector Lantigua; Lawrence J Hirsch; Stephan A Mayer; E Sander Connolly; George Hripcsak
Journal:  Ann Neurol       Date:  2013-06-27       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.